Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
This study is not yet open for participant recruitment.
Verified December 2011 by Santhera Pharmaceuticals
Information provided by (Responsible Party):
First received: December 16, 2011
Last updated: December 19, 2011
Last verified: December 2011
The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Leber's Hereditary Optic Neuropathy
Resource links provided by NLM:
Genetics Home Reference related topics: ataxia neuropathy spectrum childhood myocerebrohepatopathy spectrum deoxyguanosine kinase deficiency Leber hereditary optic neuropathy Lenz microphthalmia syndrome mitochondrial neurogastrointestinal encephalopathy disease myoclonic epilepsy myopathy sensory ataxia oculofaciocardiodental syndrome Peters plus syndromeU.S. FDA Resources
Further study details as provided by Santhera Pharmaceuticals:
Contacts and Locations
No Contacts or Locations Provided